Alison M. Hayward

The paper analyzes CGM data to understand hypoglycemia kinetics in T1D patients, leading to the development of new glucagon delivery systems for improved therapy.

The paper develops a bioresorbable implant system for long-term contraception that improves drug delivery efficiency and reduces the need for surgical intervention.

This paper develops an ingestible, battery-free robotic interface for chronic gut electrostimulation, showing it can modulate ghrelin levels and has potential for treating gastrointestinal conditions.

This paper develops an ingestible capsule that detects short-lived inflammatory biomarkers in the GI tract using genetically engineered probiotic biosensors and wireless readout technology.